Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a.
[Recommendations for a brief international cognitive assessment for multiple sclerosis].
Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination.
T(H)17 cytokines in autoimmune neuro-inflammation.
Treatment discontinuation and disease progression with injectable disease-modifying therapies: findings from the north american research committee on multiple sclerosis database.
Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis.
The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis.
The natural history of primary progressive MS in British Columbia, Canada.
Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis.
Biogen Presents New Anti-LINGO-1 Phase 2 Acute Optic Neuritis Data Demonstrating Neurological Repair
Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.
Demyelination of the hippocampus is prominent in the cuprizone model.
Neuroprotective effects of testosterone treatment in men with multiple sclerosis.
Mycophenolate mofetil in the treatment of multiple sclerosis: A preliminary report.
Teriflunomide added to interferon-β in relapsing multiple sclerosis: A randomized phase II trial.
IL-17 and Th17 Cells.
Treatment withdrawal in relapsing-remitting multiple sclerosis: a retrospective cohort study.
Transfer of interferon β-1a into human breastmilk.
Neuroprotection mediated through estrogen receptor-alpha in astrocytes.
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex (SYNERGY)
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial.
Gender and the hygiene hypothesis.
Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis.
Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations.
Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis.

Pages